⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19066548 | 1.00 | — | — | |
| SCHEMBL5691502 | 1.00 | TSHR (1.00) | — | |
| SCHEMBL203446 | 1.00 | — | — | |
| SCHEMBL1931944 | 1.00 | — | — | |
| SCHEMBL7156195 | 0.96 | — | — | |
| Ammonia Solution, Strong SCHEMBL8575322 | 0.96 | — | — | |
| Water SCHEMBL11762229 | 0.96 | — | — | |
| Potassium SCHEMBL29657178 | 0.96 | — | — | |
| SCHEMBL29569398 | 0.96 | — | — | |
| SCHEMBL27981960 | 0.96 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4476271-B1 | AN OLEFIN METATHESIS POLYMERIZATION CATALYST SYSTEM AND CURABLE COMPOSITIONS CONTAINING THE CATALYST SYSTEM | TELENE SAS (FR) | 2026-05-20 | — | — | EP | disclosed |
| EP-4157845-B1 | PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES | PFIZER (US) | 2025-08-13 | — | — | EP | disclosed |
| EP-4584266-A1 | NOVEL COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES THEREOF | Cambridge Enterprise Limited (GB) | 2025-07-16 | — | — | EP | disclosed |
| US-20250171570-A1 | An Olefin Metathesis Polymerization Catalyst System And Curable Compositions Containing The Catalyst System | TELENE SAS (FR) | 2025-05-29 | — | — | US | disclosed |
| EP-4476271-A1 | AN OLEFIN METATHESIS POLYMERIZATION CATALYST SYSTEM AND CURABLE COMPOSITIONS CONTAINING THE CATALYST SYSTEM | Telene SAS (FR) | 2024-12-18 | — | — | EP | disclosed |
| EP-3978472-B1 | BIARYL MONABACTAM COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF BACTERIAL INFECTIONS | MERCK SHARP & DOHME LLC (US) | 2024-10-16 | — | — | EP | disclosed |
| CN-108368040-B | Diaryl monocyclic beta-lactam compounds and methods for their use in the treatment of bacterial infections | 默沙东有限责任公司 | 2024-08-23 | — | — | CN | disclosed |
| CN-118525039-A | Olefin metathesis polymerization catalyst system and curable compositions containing the same | 特伦尼有限公司 | 2024-08-20 | — | — | CN | disclosed |
| WO-2024094150-A1 | NLRP3 INFLAMMASOME INHIBITORS AND USES THEREOF | INSILICO MEDICINE IP LIMITED (CN) | 2024-05-10 | — | — | WO | disclosed |
| WO-2024052701-A1 | NOVEL COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES THEREOF | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2024-03-14 | — | — | WO | disclosed |
| WO-2006045598-A1 | METHOD FOR PRODUCING CHIRAL ALCOHOLS | IEP GMBH (DE) | 2006-05-04 | — | — | WO | disclosed |
| EP-1025213-B1 | EPOXIDE HYDROLASE | PURATOS NV (BE) | 2006-04-05 | — | — | EP | disclosed |
| CN-1694883-A | Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1receptor mediated disorders | JANSSEN PHARMACEUTICA NV (BE) | 2005-11-09 | — | — | CN | disclosed |
| US-6379938-B1 | A POLYPEPTIDE DERIVED FROM RHODOCOCCUS RHODOCHROUS; FOR SYNTHESIS OF ENANTIOMERICALLY PURE COMPOUNDS | PURATOS N.V. (BE) | 2002-04-30 | — | — | US | disclosed |
| US-20020042055-A1 | Alteration of hydrolase genes and screening of the resulting libraries for the ability to catalyze specific reactions | MAXYGEN, INC. | 2002-04-11 | — | — | US | disclosed |
| WO-2001046476-A1 | ALTERATION OF HYDROLASE GENES AND SCREENING OF THE RESULTING LIBRARIES FOR THE ABILITY TO CATALYZE SPECIFIC REACTIONS | MAXYGEN, INC. (US) | 2001-06-28 | — | — | WO | disclosed |
| CN-1279714-A | Epoxide hydrolase | PURATOS NV (BE) | 2001-01-10 | — | — | CN | disclosed |
| EP-1025213-A1 | EPOXIDE HYDROLASE | PURATOS N.V. (BE) | 2000-08-09 | — | — | EP | disclosed |
| WO-1999021972-A1 | EPOXIDE HYDROLASE | PURATOS NAAMLOZE VENNOOTSCHAP (BE) | 1999-05-06 | — | — | WO | disclosed |
| EP-0911392-A1 | Epoxide hydrolase | PURATOS N.V. (BE) | 1999-04-28 | — | — | EP | disclosed |